1. Home
  2. GRFS vs GBCI Comparison

GRFS vs GBCI Comparison

Compare GRFS & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.02

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

HOLD

Current Price

$45.80

Market Cap

5.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
GBCI
Founded
1940
1955
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.9B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
GRFS
GBCI
Price
$9.02
$45.80
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$10.15
$53.60
AVG Volume (30 Days)
551.2K
875.1K
Earning Date
01-01-0001
01-22-2026
Dividend Yield
1.58%
2.88%
EPS Growth
N/A
26.70
EPS
0.64
2.05
Revenue
$8,821,017,248.00
$900,148,000.00
Revenue This Year
$5.36
$13.47
Revenue Next Year
$5.15
$27.72
P/E Ratio
$17.99
$22.33
Revenue Growth
7.31
15.35
52 Week Low
$6.19
$36.76
52 Week High
$11.14
$52.81

Technical Indicators

Market Signals
Indicator
GRFS
GBCI
Relative Strength Index (RSI) 53.16 64.29
Support Level $8.69 $44.66
Resistance Level $9.22 $46.48
Average True Range (ATR) 0.18 1.02
MACD 0.03 0.27
Stochastic Oscillator 64.15 84.38

Price Performance

Historical Comparison
GRFS
GBCI

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

Share on Social Networks: